Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Director departure
Quarterly results
Appointed director
ARADIGM CORP (ARDM) Create: Alert

All | News | Filings
Date FiledTypeDescription
03/23/2018 BW Aradigm Announces Fourth Quarter 2017 and Full Year Financial Results
11/02/2017 BW Aradigm Announces Third Quarter 2017 Financial Results
09/22/2017 BW Aradigm to Present at the Ladenburg Thalmann 2017 Healthcare Conference on September 26
09/15/2017 BW Aradigm to Host KOL Call on Infection Management in Non-Cystic Fibrosis Bronchiectasis Patients
08/10/2017 BW Aradigm Announces Second Quarter 2017 Financial Results
05/15/2017 BW Aradigm Announces First Quarter 2017 Financial Results
03/28/2017 BW Aradigm Announces Fourth Quarter 2016 and Full Year Financial Results
07/06/2011 BW Aradigm Announces Private Placement for $4.75 Million
05/12/2011 BW Aradigm Announces First Quarter 2011 Financial Results
05/03/2011 BW Aradigm to Present Additional ORBIT-2 Clinical Trial Results at Respiratory Drug Delivery Europe 2011 Conference
03/24/2011 BW Aradigm Announces Fourth Quarter 2010 and Full Year Financial Results
03/10/2011 BW Aradigm to Present at ROTH Capital Partners 23rd Annual OC Growth Stock Conference
02/17/2011 BW LifeSci Advisors Announces Investment Opinion on Aradigm Corporation
11/11/2010 BW Aradigm Announces Third Quarter 2010 Financial Results
11/04/2010 BW Aradigm Appoints Tamar Howson to Board of Directors
11/02/2010 BW Aradigm Awarded Three Therapeutic Discovery Tax Credit Grants Totaling Over $733,000 for Inhaled Liposomal Ciprofloxacin Program
10/20/2010 BW Aradigm Reports Successful Phase 2b Bronchiectasis Study with Inhaled Liposomal Ciprofloxacin
10/04/2010 BW Aradigm to Present at the 9th Annual BIO Investor Forum on October 6
09/23/2010 BW Aradigm Announces Exercise of Warrants for Proceeds of Approximately $891,000
09/20/2010 BW Aradigm Closes Equity for Debt Transaction with Novo Nordisk A/S
09/17/2010 BW Aradigm Presents Results Supporting Once-Daily Dosing With Its Inhaled Liposomal Ciprofloxacin Formulations at the 2010 European Respiratory Society (ERS) Annual Congress
08/12/2010 BW Aradigm Announces Second Quarter 2010 Financial Results
06/21/2010 BW Aradigm Announces Private Placement for $5 Million
05/17/2010 BW Aradigm Presents at the 2010 International Conference of the American Thoracic Society
03/25/2010 BW Aradigm Completes Enrollment and Doses Last Patient in Long Term Phase 2 Study of a Novel Inhaled Ciprofloxacin Formulation for the Management of Respiratory Infections in Bronchiectasis
03/23/2010 BW Aradigm Announces Fourth Quarter 2009 and Full Year Financial Results

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy